MARKET WIRECNBC • 3h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why KIDS Stock surged +2.34% Today — RQD Quant Desk Flash
$31.52 +2.34% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $31.59
OrthoPediatrics Corp. (KIDS) carries a Roarable Rating of D (Sell) with 46/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D • SELL / AVOID
Cap $823.0M
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $31.59 (+0.23%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 9/20 (D) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (46/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-6.1% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERSELL / AVOID • D
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D+
Each axis scored 0–20
12M PRICE TARGET CONE-5.4% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for KIDS)Realized 20D OHLCV Swing Band: ±10.6%
Deterministic 5-Pillar Attribution (46/100 Composite)
🔍 WHY KIDS SCORES 46/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+12/20 pts (26% of score)
Altman Z-Score 3.00 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 5/9
▲ #2 Bullish Driver: Whale & Options Positioning+11/20 pts (24% of score)
20D Institutional Volume Accumulation (±10.6% realized swing band)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade E$21.65+1.4% Next Q
38
Q2 (-2Q)Grade D$21.95+11.6% Next Q
41
Q3 (-1Q)Grade D$24.50+28.7% Next Q
43
CurrentGrade D$31.52-6.1% Hist 90D α
46
Trajectory: E (38) → D (46)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a KIDS Turnaround Squeeze
While KIDS currently carries a cautious 46/100 (D) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($23.32) and Max Pain ($33.10) forces dealer call-delta covering toward $35.19.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $KIDS• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “KIDS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why KIDS Stock surged +2.34% Today — RQD Quant Desk Flash
OrthoPediatrics Corp. (KIDS) surged +2.34% to $31.52, trading at 94% of its 52-week range ($14.42 – $32.62). Stretched risk/reward at current multiples (-7% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 94% of its 52-week range ($14.42 – $32.62) with RSI-14 at 77.8 (OVERBOUGHT (>70)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±10.6% around $31.52 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D (Sell) backed by 73.1% gross margin and $0 annual free cash flow.
Live KIDS Headlines & Catalysts
MARKET WIRECNBC • 3h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 7h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring KIDS)
- ✓Walkthrough of KIDS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
KIDS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +109.30%▲ ASCENDING CHANNEL
2026-10-30O $31.74H $31.93L $30.77C $31.52VOL 569.9K
RES: $33.25SUP: $22.14SMA50: $23.32SMA200: $19.56
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
KIDS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +15.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on KIDS today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for KIDS. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for KIDS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (KIDS)
Health Care Rank #446 of 1016
⚔️ BBNX vs KIDS Full Matrix →
1. Head-to-Head Health Care Peer Comparison (KIDS vs. BBNX, IART, SIBN, SGP)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, OrthoPediatrics Corp. (KIDS) ranks #446 by composite RQD confidence (46/100, grade D) and #382 by equity capitalization ($823.0M). Within this direct 5-issuer industry benchmark cohort, KIDS leads on earnings valuation at N/A trailing P/E, while KIDS leads on capital efficiency and profitability with -7.3% ROIC and 73.1% gross margin. SIBN currently holds the highest overall quantitative score in the immediate peer group at 48/100 (D) compared with KIDS at 46/100 (D).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| KIDS
ACTIVE
OrthoPediatrics Corp. | D | 46/100 | — | 73.1% | -7.3% | +2.34% | $823.0M | Benchmark Subject |
| BBNX Beta Bionics Inc. | D- | 36/100 | — | 55.4% | -22.1% | -1.51% | $955.8M | /bbnx-vs-kids → |
| IART Integra LifeSciences Holdings Corporation | E | 32/100 | — | 50.9% | -35.0% | +4.82% | $998.2M | /iart-vs-kids → |
| SIBN SI-BONE Inc. | D | 48/100 | — | 79.6% | -10.3% | +2.66% | $1.00B | /sibn-vs-kids → |
| SGP SpyGlass Pharma Inc. | D- | 41/100 | — | — | -35.0% | -1.06% | $1.09B | /sgp-vs-kids → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001425450In its most recent audited fiscal period (FY2025, filed 2025-12-31), OrthoPediatrics Corp. (KIDS) reported GAAP revenue of $236.3M (+15.4% vs. FY2024 revenue of $204.7M , and +58.9% cumulative change since FY2023) , GAAP net income of -$39.6M, operating cash flow of -$4.9M, and free cash flow of -$16.0M (+61.4% YoY). On the balance sheet, KIDS closed FY2025 with $508.6M in total assets against $99.8M in total debt (Altman Z-Score: 3.00, Piotroski F-Score: 5/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $236.3M | -$39.6M | -$4.9M | -$16.0M | $508.6M | $99.8M |
| FY2024 (FY) | 2024-12-31 | $204.7M | -$37.8M | -$27.0M | -$41.3M | $473.2M | $73.0M |
| FY2023 (FY) | 2023-12-31 | $148.7M | -$21.0M | -$27.0M | -$27.0M | — | — |
3. KIDS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs KIDS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, OrthoPediatrics Corp. (NASDAQ: KIDS) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $31.52 (+2.34% 1D, market cap $823.0M). Pillar breakdown: Fundamental Cash Engine 9/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, KIDS ranks #446 in composite RQD confidence.
How does KIDS compare to BBNX and IART in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), KIDS carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of 73.1%, and ROIC of -7.3%. By comparison, BBNX (Beta Bionics Inc.) holds a D- grade (36/100 RQD, P/E N/A, ROIC -22.1%, cap $955.8M) and IART (Integra LifeSciences Holdings Corporation) posts a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $998.2M). Among the 5-stock peer group, KIDS leads on earnings multiple (N/A) while KIDS leads on capital efficiency (-7.3% ROIC).
What are the biggest fundamental strengths and SEC risk factors for KIDS?
Per KIDS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001425450), OrthoPediatrics Corp. generated $236.3M in revenue (+15.4% YoY), -$39.6M in net income, and -$16.0M in free cash flow against $508.6M in total assets and $99.8M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is KIDS trading relative to its 50-day, 200-day, and 52-week technical levels?
KIDS last traded at $31.52 (+2.34% on volume of 835,010 shares), positioning the stock +35.16% above its 50-day simple moving average ($23.32) and +61.15% above its 200-day simple moving average ($19.56). Across its 52-week range of $14.42 to $32.62, KIDS sits at the 94.0% percentile with a 14-day RSI of 77.8 (OVERBOUGHT (>70)) and an implied next-earnings move of ±10.6% ($28.18 to $34.86).
KIDS Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is KIDS stock moving today?
Why KIDS Stock surged +2.34% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-7% return on capital) under elevated 10-year interest-rate pressure.